Item 2.02 Results of Operations and Financial Condition

On August 6, 2020, Ziopharm Oncology, Inc., or the Company, issued a press release announcing its financial condition and results of operations for the three months ended June 30, 2020. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

This information, including the information contained in the press release furnished as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any of the Company's filings, whether made before or after the date hereof, regardless of any general incorporation language in any such filing.

Item 9.01 Financial Statements and Exhibits






  (d) Exhibits




Exhibit
  No.        Description

99.1           Press Release of Ziopharm Oncology, Inc. dated August 6, 2020

10.4         Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses